🔗 Share this article

A senior citizen grew accustomed to receiving Aida's daily call each morning.

A routine morning call from an AI voice bot was not part of the service Rolls expected when she signed up for St Vincent’s in-home support but when they asked to participate in the pilot program four months ago, the 79-year-old said yes because she wanted to help. Although, truth be told, her expectations were low.

Nevertheless, when she got the call, she states: “I was so overtaken by how interactive she was. It was impressive for a robot.”

“She’d always ask ‘how you are today?’ and that gives you an opportunity if you’re feeling sick to say you felt sick, or I just say ‘I’m fine, thank you’.”

“The AI would then pose follow-up questions – ‘did you manage to go outdoors today?’”

Aida would also inquire about what Rolls had planned for the day and “it would reply appropriately.”

“When I mentioned I’m going shopping, she’d say are you shopping for clothes or groceries? I found it entertaining.”

Bots Easing the Administrative Burden on Healthcare Staff

The trial, which has now wrapped up its first phase, is an example in which progress in AI technology are being taken up in the medical field.

Digital health company the provider partnered with St Vincent’s regarding the trial to use its advanced AI system to provide social interaction, as well as an opportunity for home care clients to log any health issues or concerns for a staff member to address.

Dean Jones, national director of St Vincent’s At Home, explains the AI check-in under evaluation does not replace any in-person visits.

“Clients still receive a regular personal visit, but in between visits … the automated system allows a daily check-in, which can then escalate any potential concerns to either our team or a client’s family,” Jones says.

The managing director, the managing director of the company, reports there have been no any negative events noted from the St Vincent’s trial.

Healthily employs advanced AI “with strict safety protocols” to guarantee the conversation is secure and mechanisms are established to address critical medical problems quickly, the director says. For example, if a client is reporting heart symptoms, it would be flagged to the care team and the conversation terminated so the person could call emergency services.

Campbell believes AI has an significant part amid significant workforce challenges across the medical industry.

“What we can do very safely, using such systems, is reduce the administrative load on the workforce so qualified health professionals can focus on performing the duties that they’re trained to do,” she says.

Artificial Intelligence Long Established as You Might Think

Prof Enrico Coiera, the founder of the Australian Alliance for Artificial Intelligence in Healthcare, says established types of artificial intelligence have been a standard part of medicine for a long time, often in “administrative functions” such as analyzing scans, ECGs and pathology test results.

“Software that performs a task that requires judgment in some way is AI, irrespective of how it accomplishes it,” says Coiera, who is additionally the director of the Centre for Health Informatics at Macquarie University.

“When visiting the imaging department, medical imaging center or pathology lab, you will find software in machines performing these tasks.”

Over the past decade, advanced versions of artificial intelligence known as “deep learning” – a neural network method that allows systems to learn from very large sets of data – have been used to read medical imaging and enhance detection, Coiera notes.

In November, BreastScreen NSW became the nation's pioneering public health initiative to introduce machine reading technology to assist specialists in interpreting a specific set of breast scans.

These represent specialized tools that still require a specialist doctor to interpret the findings they could indicate, and the responsibility for a medical decision rests with the healthcare provider, the professor says.

AI’s Role in Early Disease Detection

The Murdoch Children’s Research Institute in Melbourne has been collaborating with researchers from a UK university who first developed AI methods to detect epilepsy brain abnormalities known as focal cortical dysplasias from brain scans.

These abnormalities cause epileptic episodes that crequently cannot be controlled with medication, so surgical intervention to excise the tissue becomes the sole option. However, the procedure can only be performed if the doctors can locate the abnormal tissue.

A study published this week in the scientific publication, a group from the research body, led by neurologist Emma Macdonald-Laurs, demonstrated their “neural network tool” could identify the lesions in up to 94% of instances from advanced imaging in a specific form of the malformations that have historically been missed in the majority of cases (60%).

The AI was developed using the scans of 54 patients and then evaluated with pediatric cases and 12 adults. Of the 17 children, 12 had surgery and eleven became free of seizures.

This technology employs neural network classifiers similar to the breast cancer screening – flagging regions of abnormality, which are still checked by experts “speeding up the process to reach a conclusion,” the researcher says.

She emphasises the researchers are currently in initial stages of the work, with a further study required to get the technology heading towards clinical implementation.

A leading neurologist, a neurologist who was independent from the study, notes MRI scans now generate such vast quantities of detailed information that it is hard for a human to review it accurately. Thus for clinicians the challenge of locating these lesions was like “identifying the needle in the haystack.”

“It’s a great demonstration of how artificial intelligence can support doctors in making earlier, precise identifications, and has the potential to improve operation opportunities and outcomes for kids with otherwise intractable epilepsy,” Cook says.

Disease Detection in the Future

Dr Stefan Buttigieg, the vice-president of the European Public Health Association’s digital health and artificial intelligence section, explains deep neural networks are additionally used to track and forecast disease outbreaks.

Buttigieg, who presented last month at the Public Health of Australia’s conference in the city, gave as an example Blue Dot, a organization established by infectious disease specialists and which was an early detector to identify the Covid-19 outbreak.

Generative AI is a additional branch of deep learning, in which the technology can produce original material using training data. These uses in medicine include programs such as Healthily’s AI voice bot as well as the automated note-takers doctors and allied health professionals are increasingly using.

Dr Michael Wright, the head of the national GP body, says family doctors have been adopting AI scribes, which records the appointment and turns into a consultation note that can be added to the health file.

Wright states the primary advantage of the tools is that it improves the quality of the interaction between the doctor and patient.

A medical leader, the chair of the national doctors' group, concurs that AI note-takers are assisting physicians manage schedules and adds artificial intelligence can also help to prevent repeated examinations and imaging for their clients, if the {promised digitisation|planned digitalization